Options Brief: ARIAD Pharmaceuticals, Inc.

Shares of ARIAD Pharmaceuticals, Inc. ARIA are higher on the session by 2.65%, trading at $11.24. Overall put volume is now running at 4.15x the daily average, with 6% of all puts traded being purchases on the offer. 13,055 contracts have traded on the session so far. ARIAD Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of drugs to provide therapeutic intervention in treating human diseases at the cellular level.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: OptionsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!